Details for New Drug Application (NDA): 210557
✉ Email this page to a colleague
The generic ingredient in VYLEESI (AUTOINJECTOR) is bremelanotide acetate. One supplier is listed for this compound. Additional details are available on the bremelanotide acetate profile page.
Summary for 210557
Tradename: | VYLEESI (AUTOINJECTOR) |
Applicant: | Cosette |
Ingredient: | bremelanotide acetate |
Patents: | 5 |
Pharmacology for NDA: 210557
Mechanism of Action | Melanocortin Receptor Agonists |
Suppliers and Packaging for NDA: 210557
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557 | NDA | Palatin Technologies | 80064-141 | 80064-141-02 | 2 SYRINGE in 1 CARTON (80064-141-02) / .3 mL in 1 SYRINGE (80064-141-01) |
VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557 | NDA | Palatin Technologies | 80064-141 | 80064-141-04 | 4 SYRINGE in 1 CARTON (80064-141-04) / .3 mL in 1 SYRINGE (80064-141-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;SUBCUTANEOUS | Strength | EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML) | ||||
Approval Date: | Jun 21, 2019 | TE: | RLD: | Yes | |||||
Regulatory Exclusivity Expiration: | Jun 21, 2024 | ||||||||
Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 5, 2033 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 29, 2041 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATING ACQUIRED, GENERALIZED HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN A PREMENOPAUSAL FEMALE PATIENT WITH CONTROLLED HYPERTENSION BY INJECTING BREMELANOTIDE MORE THAN ONCE WITH AT LEAST 24 HOURS BETWEEN DOSES AND NO MORE THAN 8 DOSES PER MONTH |
Expired US Patents for NDA 210557
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription